Effect of the Subconscious on Mohs Micrographic Surgery

Not Applicable

Completed

• Conditions: Basal Cell Carcinoma; Squamous Cell Carcinoma
• Interventions: Behavioral: relaxation therapy 3; Behavioral: relaxation therapy 1; Behavioral: relaxation therapy 2

• Registration Number: NCT00374062
• Lead Sponsor: Northwestern University

Brief Summary

The goal of this study is to determine if relaxation therapy improves patient satisfaction with Mohs micrographic surgery.

Detailed Description

Patients are instructed in relaxation techniques. The goal of this study is to determine how relaxation techniques affect the patient's Mohs micrographic surgery experience.

Study Timeline

• Study First Submitted: 2006-09-07
• Study First Submitted QC: 2006-09-07
• Study First Posted: 2006-09-08
• Study Start: 2007-12
• Primary Completion: 2009-08
• Study Completion: 2009-08
• Status Verified: 2014-07
• Last Update Submitted: 2014-07-14
• Last Update Posted: 2014-07-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Age 25 and older
• Subjects are undergoing micrographic Mohs surgery for facial basal and squamous cell carcinoma.
• The subjects are in good health.
• The subjects have willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Exclusion Criteria

• Subjects who have wound healing problems.
• Subjects who have had prior Mohs surgery.
• Subjects who are smokers.
• Subjects who are currently using anticoagulation therapy
• Subjects who have a history of bleeding disorders.
• Subjects who are unable to understand the protocol or to give informed consent
• Subjects with known mental illness or other psychological conditions, such as psychotic disorders, mood disorders, anxiety disorders, cognitive disorders, depression with psychotic features, dissociative disorders.
• Subjects who are taking medications that may affect healing such as prednisone, or any immunosuppressants.
• Subjects who are immunocompromised.
• Subjects who have Diabetes Mellitus or any other condition determined by the PI to affect healing.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
III	relaxation therapy 3	relaxation tape 3
I	relaxation therapy 1	relaxation tape 1
II	relaxation therapy 2	relaxation tape 2

Primary Outcome Measures

Name	Time	Method
Patient anxiety	1 day

Secondary Outcome Measures

Name	Time	Method
Scar appearance	12 weeks

Trial Locations

Locations (1)

Murad Alam, MD; 🇺🇸 Chicago, Illinois, United States